Wednesday, September 12, 2018 1:29:38 PM
Today's press release:
This acceptance as a presentation of late-breaking clinical trial results is based on the ability of REDUCE-IT to address a critical question in cardiovascular prevention. The AHA has reviewed the design of the REDUCE-IT study, however, they have not yet seen the results of the study. As Amarin has guided in the past, topline results of this study are anticipated to be made public prior to the end of this month, September 2018. The AHA has not been provided any advanced access to the results of this study.
Notice they stated that the AHA has NOT yet seen the results of the study. Notice that it did not state that Amarin hasn't seen it like JT has said in the past. To push to present at the AHA w/ knowledge of the result is a positive as they would not be in a hurry if it was negative. Also, you can not provide advanced access to the results if you don't have it. You'd simply say we still do not have the results.
Essentially we know they have the results. The question is whether they completely understand it and that is the sole reason why it has not been PR'ed yet. I could be reading into something that isn't there or wasn't intentional but the way its written subtly implies they have it and by PR'ing their push to present it asap, reflects what is likely a positive outcome.
Recent A News
- Agilent to Host Analyst and Investor Day on Dec. 17, 2024 • Business Wire • 09/30/2024 09:17:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 05:08:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2024 09:02:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/27/2024 04:19:41 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/26/2024 06:52:56 PM
- Agilent Completes Acquisition of BIOVECTRA • Business Wire • 09/20/2024 03:01:00 PM
- Agilent Announces Cash Dividend of 23.6 Cents per Share • Business Wire • 09/18/2024 08:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:13:59 PM
- Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine • Business Wire • 09/09/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 09:28:00 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 09/04/2024 10:18:47 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/04/2024 12:25:43 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 09/03/2024 01:12:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 03:43:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2024 04:39:33 PM
- Schwab and Snowflake Retreat in Premarket, WeRide Postpones IPO, Halliburton Cyberattack, McDonald’s Instagram Hack • IH Market News • 08/22/2024 09:37:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:06:43 PM
- Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results • Business Wire • 08/21/2024 08:05:00 PM
- Agilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance • Business Wire • 08/15/2024 12:00:00 PM
- Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy • Business Wire • 08/02/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 02:42:22 PM
- Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology • Business Wire • 07/29/2024 01:55:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/26/2024 02:56:45 PM
- Johnson Controls Division Sold for $8 Billion; Alphabet’s Offer Rejected by Wiz; AMD President Announces Retirement • IH Market News • 07/23/2024 10:00:52 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 07/22/2024 08:33:23 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM